Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

A Study of Golimumab in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Orchard Park, NY
A Study of Golimumab in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Orchard Park, NY
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Salisbury, NC
A Study of Golimumab in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Salisbury, NC
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Duncansville, PA
A Study of Golimumab in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Austin, TX
A Study of Golimumab in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/20/2017
Site Reference ID/Investigator# 130384
mi
from
Daw Park,
A Study of Golimumab in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Site Reference ID/Investigator# 130384
mi
from
Daw Park,
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Pinnacle Research Group, LLC
mi
from
Anniston, AL
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Pinnacle Research Group, LLC
mi
from
Anniston, AL
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Rheumatology Associates, PC
mi
from
Birmingham, AL
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Rheumatology Associates, PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Achieve Clinical Research
mi
from
Birmingham, AL
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Achieve Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Arizona Arthritis and Rheumatology Research
mi
from
Glendale, AZ
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Arizona Arthritis and Rheumatology Research
mi
from
Glendale, AZ
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Arizona Arthritis & Rheumatology Research, PLLC
mi
from
Mesa, AZ
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Arizona Arthritis & Rheumatology Research, PLLC
mi
from
Mesa, AZ
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Arizona Arthritis & Rheumatology Research PLLC
mi
from
Phoenix, AZ
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Arizona Arthritis & Rheumatology Research PLLC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
TriWest Research Associates, LLC
mi
from
El Cajon, CA
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
TriWest Research Associates, LLC
mi
from
El Cajon, CA
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Advanced Medical Research, LLC
mi
from
La Palma, CA
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Advanced Medical Research, LLC
mi
from
La Palma, CA
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
ProHealth Partners
mi
from
Long Beach, CA
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
ProHealth Partners
mi
from
Long Beach, CA
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
The Permanente Medical Group
mi
from
Santa Clara, CA
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
The Permanente Medical Group
mi
from
Santa Clara, CA
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Inland Rheumatology Clinical Trials, Inc.
mi
from
Upland, CA
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Inland Rheumatology Clinical Trials, Inc.
mi
from
Upland, CA
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Medvin Clinical Research
mi
from
Whittier, CA
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Medvin Clinical Research
mi
from
Whittier, CA
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Alpine Clinical Research Center
mi
from
Boulder, CO
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Alpine Clinical Research Center
mi
from
Boulder, CO
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Orthopedic Research Institute
mi
from
Boynton Beach, FL
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Orthopedic Research Institute
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Clinical Research of West Florida
mi
from
Clearwater, FL
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Clinical Research of West Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Universal Clinical Research
mi
from
Coral Gables, FL
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Universal Clinical Research
mi
from
Coral Gables, FL
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Science and Research Institute
mi
from
Jupiter, FL
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Science and Research Institute
mi
from
Jupiter, FL
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
San Marcus Research Clinic
mi
from
Miami, FL
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
San Marcus Research Clinic
mi
from
Miami, FL
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
L&C Professional Medical Research Institute
mi
from
Miami, FL
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
L&C Professional Medical Research Institute
mi
from
Miami, FL
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Family Clinical Trials, Incorporated
mi
from
Pembroke Pines, FL
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Family Clinical Trials, Incorporated
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Physician Research Collaboration
mi
from
South Miami, FL
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Physician Research Collaboration
mi
from
South Miami, FL
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
West Broward Rheumatology Associates, Incorporated
mi
from
Tamarac, FL
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
West Broward Rheumatology Associates, Incorporated
mi
from
Tamarac, FL
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Clinical Research of West Florida, Inc.
mi
from
Tampa, FL
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Clinical Research of West Florida, Inc.
mi
from
Tampa, FL
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
McIlwain Medical Group
mi
from
Tampa, FL
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
McIlwain Medical Group
mi
from
Tampa, FL
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Lovelace Scientific Resources, Incorporated
mi
from
Venice, FL
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Lovelace Scientific Resources, Incorporated
mi
from
Venice, FL
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Institute of Arthritis Research
mi
from
Idaho Falls, ID
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Institute of Arthritis Research
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Goldpoint Clinical Research
mi
from
Indianapolis, IN
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Heartland Research Associates, LLC
mi
from
Wichita, KA
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Heartland Research Associates, LLC
mi
from
Wichita, KA
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
The Arthritis & Diabetes Clinic, Incorporated
mi
from
Monroe, LA
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
The Arthritis & Diabetes Clinic, Incorporated
mi
from
Monroe, LA
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Klein & Associates, MD, PA
mi
from
Cumberland, MD
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Klein & Associates, MD, PA
mi
from
Cumberland, MD
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Clinical Pharmacology Study Group
mi
from
Worcester, MA
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Clinical Pharmacology Study Group
mi
from
Worcester, MA
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Henry Ford Health System
mi
from
Detroit, MI
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Arthritis Education and Treatment Center
mi
from
Grand Rapids, MI
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Arthritis Education and Treatment Center
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
North MS Medical Clinics, Incorporated
mi
from
Tupelo, MS
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
North MS Medical Clinics, Incorporated
mi
from
Tupelo, MS
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Glacier View Research Institute
mi
from
Kalispell, MT
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Glacier View Research Institute
mi
from
Kalispell, MT
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Accurate Clinical Research, Inc.
mi
from
Lincoln, NE
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Accurate Clinical Research, Inc.
mi
from
Lincoln, NE
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
NJP Clinical Research
mi
from
Clifton, NJ
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
NJP Clinical Research
mi
from
Clifton, NJ
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Albuquerque Center For Rheumatology
mi
from
Albuquerque, NM
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Albuquerque Center For Rheumatology
mi
from
Albuquerque, NM
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Anna Imperato, MD PLLC
mi
from
Manhasset, NY
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Anna Imperato, MD PLLC
mi
from
Manhasset, NY
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Box Arthritis & Rheumatology of the Carolinas
mi
from
Charlotte, NC
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Box Arthritis & Rheumatology of the Carolinas
mi
from
Charlotte, NC
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Medication Management, LLC
mi
from
Greensboro, NC
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Medication Management, LLC
mi
from
Greensboro, NC
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Pmg Research Of Salisbury
mi
from
Salisbury, NC
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Pmg Research Of Salisbury
mi
from
Salisbury, NC
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
STAT Research, Incorporated
mi
from
Dayton, OH
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
STAT Research, Incorporated
mi
from
Dayton, OH
Click here to add this to my saved trials
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated:  12/20/2017
Clinical Research Source, Inc.
mi
from
Perrysburg, OH
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
Efficacy, Safety and Immunogenicity of BI 695501 Versus Adalimumab in Patients With Active Rheumatoid Arthritis: a Randomized, Double-blind,Parallel Arm, Multiple Dose, Active Comparator Trial
Status: Enrolling
Updated: 12/20/2017
Clinical Research Source, Inc.
mi
from
Perrysburg, OH
Click here to add this to my saved trials